This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Global Pharmaceutical Regulatory Affairs Summit
22-24 October 2024
Sheraton Brussels Airport, BrusselsHybrid Event

Laurent Lefebvre
Regulatory CMC Director at Novartis Pharma AG
Speaker

Profile

Pharmacist working as Director in RA GDD CMC at the Novartis HQ in Basel Switzerland. 10 years of experience working as worldwide Regulatory CMC Project Lead including blockbuster brands which helped to develop a good overview of the entire CMC product lifecycle in a global regulatory environment. Core team member of the Novartis Regulatory Strategy and Intelligence for IDMP since 2014 and member of the EFPIA ICH M4Q support team. Involved in regular collaborations cross-industry (IDMP roundtables, Pistoia Alliance), digital initiatives (RIM structured authoring, master data & PLM), reviewer of the ISO IDMP guidelines and Novartis contributor to regulatory intelligence discussions regarding telematics (EMA SPOR, KASA-PQ/CMC, G-SRS...), including contribution and review of EFPIA / Pharma position papers and currently acting as EFPIA Alternate Expert in the ICHM4Q(R2) EWG

Agenda Sessions

  • Current State of Play: ICH M4Q

    12:10
  • Looking to the Future: Regulating Pharmaceuticals in Europe

    17:00